Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MXCT MaxCyte > Main Composition
MXCT MaxCyte
5.610
+0.180+3.31%
Post Mkt Price
5.6100.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Single Segment--33.89M100.00%
Region Unit:USD
nameYOYOperating income%
United States--33.89M100.00%
Company Overview More
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
CEO: Mr. Douglas Arthur Doerfler
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist